|

BL-M05D1 Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Pipeline

Phase 1: 2Phase 3: 1

Top Sponsors

  • Sichuan Baili Pharmaceutical Co., Ltd.2
  • SystImmune Inc.1

Indications

  • Cancer3
  • Advanced Pancreatic Ductal Adenocarcinoma1
  • Other Solid Tumors1
  • Gastroesophageal Junction Adenocarcinoma1
  • Gastric Adenocarcinoma1

Other2 trials

A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
Phase 3
A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1

Phoenix, Arizona1 trial

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

Mayo Clinic Cancer Center- Phoenix

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.